The effectiveness and cost-effectiveness of biologic therapies for psoriasis are significantly compromised by variable treatment responses. Thus, more precise management of psoriasis is needed.We aim to identify subgroups of psoriasis …
Development of a shared decision-making tool in vitiligo: an international study.
Shared Decision-Making tools (SDMt) are visual tools developed to promote joint medical decision-making between physician and patient. In dermatology, there is a paucity of such tools.To develop and validate a …
Mucosal Kaposi’s sarcoma in HIV-negative patients: a large case series from a single, tertiary referral center in Italy.
Mucosal involvement in HIV-negative Kaposi’s sarcoma (KS) is uncommon but has potentially serious repercussions on patient care. Evidence regarding its epidemiology and optimal management is limited. Invasive endoscopic staging at …
The risk of malignancy in secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis patients: analysis of up to five-year clinical trial and post-marketing surveillance data.
Data on the use of biologic therapy and malignancy risk are inconsistent due to limited long-term robust studies.To assess the malignancy risk in secukinumab-treated psoriasis, psoriatic arthritis (PsA) and ankylosing …
Systemic Inflammatory Disease Tied to Mortality After MI in Young Adults
During follow-up, patients had increased risk for all-cause mortality
Poll: Public Lost Trust in CDC During COVID-19 Crisis
During recent survey period, trust in the CDC dropped about 10 percent